CELLENKOS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Nov 2024)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87581177
- Registration number
- 5499487
- Mark type
- Stylized text
- Filed
- 23 Aug 2017
- Published for opposition
- 09 Jan 2018
- Registered
- 19 Jun 2018
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 042 — Scientific and technological services: Scientific Research; Stem cell research services; Research and development regarding cell therapy; medical and scientific research in the field of cord blood regulatory T-cell therapeutics
Owner
- Cellenkos, Inc., Houston, TX, US
- Cellenkos, Inc., Houston, TX, US
- Cellenkos, Inc., Houston, TX, US
Prosecution history
- 28 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 19 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 18 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Apr 2018 — USE AMENDMENT FILED
- 01 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Apr 2018 — TEAS STATEMENT OF USE RECEIVED